Gregory Bordan

Subscribe to all posts by Gregory Bordan

Quebec Prohibits Financial Assistance by Drug Manufacturer for Patients’ Drug Costs

By Gregory Bordan and Kimberly Jeffers on April 29, 2021 Posted in Life sciences and healthcare, Pharmaceuticals and life sciences

At the end of 2016, the previous Quebec government prohibited a number of common commercial practices by drug manufacturers and pharmacists with the aim of fostering greater price competition between drug manufacturers and reducing the cost of the public drug insurance scheme.[1] Among the new prohibitions was one that would prohibit a manufacturer from offering … Continue reading

Quebec Court of Appeal overturns minister’s decision to remove Remicade from Quebec’s List of Medications

By Gregory Bordan on February 10, 2019 Posted in Life sciences and healthcare, Pharmaceuticals and life sciences

The Quebec Court of Appeal has declared a decision by the Minister of Health and Social Services to “delist” Remicade from Quebec’s List of Medications (Quebec’s equivalent to a formulary) to be invalid and has ordered the minister to reinstate the drug on the list. Two takeaways from this decision: the minister’s decisions to list … Continue reading

Bill 148 : A Bill to limit generic medication procurement by owner pharmacists

By Veronique Barry and Gregory Bordan on November 7, 2017 Posted in Pharmaceuticals and life sciences

Bill 148, An Act to regulate generic medication procurement by owner pharmacists and to amend various legislative provisions, was tabled in the National Assembly on October 5. It will amend An Act respecting Prescription Drug Insurance, introducing the Regulation to govern generic medication procurement by owner pharmacists. The new Regulation will provide, subject to certain exceptions, … Continue reading